AXGN

#1876
Axogen, Inc. Common Stock
31.7300
+2.40%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
31.7300
31.7300
Intervallo Annuale
17.1400
35.9999
Variazione giornaliera
+2.40%
Variazione Mensile
-8.27%
Variazione di 6 mesi
+73.96%
Variazione Annuale
+73.96%
Chiusura Precedente
30.9850
Open
31.7300
Bid
Ask
Low
31.7300
High
31.7300
Volume
118
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.4612 B
  • Employee 452
  • Founded 2002
  • CEO N/A
  • Website www.axogeninc.com
  • Headquarter Minnesota, United States
  • FIGI BBG000BN46R9
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-96.26
Price to sales ratio
6.69
Dividends per share
—
Dividend yield %
—

Axogen Inc

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

Notizie